Menu
Currency
GWAS Study

Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.

Hu L, Wu C, Zhao X et al.

22872573 PubMed ID
GWAS Study Type
1277 Participants
40 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HL
Hu L
WC
Wu C
ZX
Zhao X
HR
Heist R
SL
Su L
ZY
Zhao Y
HB
Han B
CS
Cao S
CM
Chu M
DJ
Dai J
DJ
Dong J
SY
Shu Y
XL
Xu L
CY
Chen Y
WY
Wang Y
LF
Lu F
JY
Jiang Y
YD
Yu D
CH
Chen H
TW
Tan W
MH
Ma H
CJ
Chen J
JG
Jin G
WT
Wu T
LD
Lu D
CD
Christiani DC
LD
Lin D
HZ
Hu Z
SH
Shen H
Chapter II

Abstract

Summary of the research findings

Purpose: Genetic variation may influence chemotherapy response and overall survival in cancer patients.

528 Han Chinese ancestry cases

Chapter III

Study Statistics

Key metrics and study information

1277
Total Participants
GWAS
Study Type
Yes
Replicated
340 Han Chinese ancestry cases, 409 European ancestry cases
Replication Participants
East Asian, European
Ancestry
China, U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.